Patents by Inventor Michael Scannell

Michael Scannell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230420124
    Abstract: A method includes generating, using one or more sensors, data. The data includes (i) environmental data related to an environment of a user and (ii) physiological data associated with the user during a sleep session. Based at least in part on the physiological data, a comfort score associated with the user during the sleep session is determined. The comfort score is indicative of a comfort level of the user during at least a portion of the sleep session. Based at least in part on the determined comfort score, a setting of one or more devices associated with the environment of the user is adjusted.
    Type: Application
    Filed: November 19, 2021
    Publication date: December 28, 2023
    Inventors: Roxana Tiron, Michael Scannell, Kieran Conway, Redmond Shouldice
  • Patent number: 10167247
    Abstract: There is provided individual polymorphic forms of treprostinil and pharmaceutical formulations comprising the same, methods of making and using the same.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: January 1, 2019
    Assignee: United Therapeutics Corporation
    Inventors: Kenneth Phares, Michael Scannell
  • Publication number: 20180072649
    Abstract: There is provided individual polymorphic forms of treprostinil and pharmaceutical formulations comprising the same, methods of making and using the same.
    Type: Application
    Filed: October 25, 2017
    Publication date: March 15, 2018
    Applicant: United Therapeutics Corporation
    Inventors: Kenneth Phares, Michael SCANNELL
  • Patent number: 9822057
    Abstract: There is provided individual polymorphic forms of treprostinil and pharmaceutical formulations comprising the same, methods of making and using the same.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 21, 2017
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, Michael Scannell
  • Publication number: 20140275262
    Abstract: There is provided individual polymorphic forms of treprostinil and pharmaceutical formulations comprising the same, methods of making and using the same
    Type: Application
    Filed: March 7, 2014
    Publication date: September 18, 2014
    Applicant: United Therapeutics Corporation
    Inventors: Ken Phares, Michael Scannell
  • Patent number: 7342003
    Abstract: Provided is a method for the synthesis of an aralkyloxyadenosine or an alkoxyadenosine. The method includes protecting the hydroxyl sugar groups with a protecting group to produce a protected halogenated adenosine. The protected halogenated adenosine is alkoxylated, and the hydroxyl sugar groups of the protected halogenated adenosine are deprotected to provide the aralkyloxyadenosine or alkoxyadenosine.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: March 11, 2008
    Assignee: King Pharmaceuticals Research and Development, Inc.
    Inventors: Allan R. Moorman, Michael Scannell, Thiagarajan Balasubramanian, Russell Outcalt, Edward Leung
  • Publication number: 20060135466
    Abstract: Provided is a method for the synthesis of an aralkyloxyadenosine or an alkoxyadenosine. The method includes protecting the hydroxyl sugar groups with a protecting group to produce a protected halogenated adenosine. The protected halogenated adenosine is alkoxylated, and the hydroxyl sugar groups of the protected halogenated adenosine are deprotected to provide the aralkyloxyadenosine or alkoxyadenosine.
    Type: Application
    Filed: June 16, 2005
    Publication date: June 22, 2006
    Inventors: Allan Moorman, Michael Scannell, Thiagarajan Balasubramanian, Russell Outcalt